抗体検査の世界市場

• 英文タイトル:Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand

Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand「抗体検査の世界市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR201210
• 出版社/出版日:Persistence Market Research / 2020年9月29日
• レポート形態:英文、PDF、235ページ
• 納品方法:Eメール
• 産業分類:生命科学
• 販売価格(消費税別)
  Single User¥509,600 (USD4,900)▷ お問い合わせ
  Site Licence¥790,400 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,102,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは抗体検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、主要成功要因、市場価値分析・予測、製品別(キット、化学薬品および試薬、消耗品)分析、効能別(妊娠、心血管疾患、自己免疫疾患、感染症、腫瘍学)分析、最終用途別(病院、学術研究所、診断研究所、バイオ製薬会社、在宅医療)分析、地域別分析、主要・新興国分析、市場構造分析、競争分析、仮定、調査手法
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・主要成功要因
・市場価値分析・予測
・抗体検査の世界市場規模:製品別(キット、化学薬品および試薬、消耗品)
・抗体検査の世界市場規模:疾患別(妊娠、心血管疾患、自己免疫疾患、感染症、腫瘍学)
・抗体検査の世界市場規模:最終用途別(病院、学術研究所、診断研究所、バイオ製薬会社、在宅医療)
・抗体検査の世界市場規模:地域別
・主要・新興国分析
・市場構造分析
・競争分析
・仮定
・調査手法

Antibody Testing Market – Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global antibody testing market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global antibody testing market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities of the antibody testing market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the antibody testing market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers to know the demand for antibody testing and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the antibody testing market, including antibody testing market investors and service providers, and can help them in developing suitable business strategies to flourish in the antibody testing market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the antibody testing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibody testing market are also included in the current study. Depending on potential developments in the antibody testing market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibody testing industry can be aided in making suitable company choices to achieve traction in the antibody testing market.

Key Questions Answered in PMR’s Antibody Testing Market Report

Which regions will continue to remain the most profitable regional markets for antibody testing market players?
Which factors will induce a change in the demand for antibody testing during the assessment period?
How will COVID-19 change the trends in the antibody testing market?
How can market players capture the low-hanging opportunities in the antibody testing market in developed regions?
What are the winning strategies of stakeholders in the antibody testing market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and tackle while investing in antibody testing market?
What are the developmental trends in antibody testing sectors that will impact the market?
How can businesses in the antibody testing market avail the growth opportunities in developed and emerging economies?
Antibody Testing Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibody testing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the antibody testing market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals, and research scholars using antibody-based test kits, and key executives of product manufacturing companies, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the antibody testing market, and makes PMR’s projections on the growth prospects of the antibody testing market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Market Evolution

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Demand Side Trends

3.2. Supply Side Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global Healthcare Outlook

4.1.2. Global Biotech and Biopharma Industry Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Prevalence of Various Diseases

4.2.2. Historic Growth of Key Manufacturers

4.2.3. Adoption of Antibody Testing Kits

4.2.4. Product in Pipeline

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

4.4. COVID-19 Analysis

5. Key Success Factors

5.1. Diseases Epidemiology

5.2. Regulatory Landscape

5.3. Pipeline Assessment

5.4. Key Strategies by Manufacturer

6. Global Antibody Testing Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

7. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Product

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product, 2015–2019

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030

7.3.1. Kits

7.3.1.1. Serological Test Kits

7.3.1.1.1. Serological Assay Test Kits

7.3.1.1.2. Serological Rapid Assay Kits

7.3.1.2. Immunoglobulin Kits

7.3.1.2.1. Immunoglobulin Assay Test Kits

7.3.1.2.2. Immunoglobulin Rapid Assay Kits

7.3.1.3. Lateral Flow Assay Kits

7.3.1.3.1. Lateral Flow Assay Test Kits

7.3.1.3.2. Lateral Flow Rapid Assay Kits

7.3.2. Chemical and Reagents

7.3.3. Consumables

7.4. Market Attractiveness Analysis By Product Type

8. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015–2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030

8.3.1. Pregnancy

8.3.2. Cardiovascular Diseases

8.3.3. Autoimmune Diseases

8.3.4. Infectious Diseases

8.3.5. Oncology

8.3.6. Endocrine Diseases

8.3.7. Diabetes

8.3.8. Others

8.4. Market Attractiveness Analysis By Indication

9. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

9.3.1. Hospitals

9.3.2. Academic and Research Institutes

9.3.3. Diagnostic Laboratories

9.3.4. Biopharmaceutical Companies

9.3.5. Homecare Settings

9.4. Market Attractiveness Analysis By End User

10. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Region

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. East Asia

10.3.5. South Asia

10.3.6. Oceania

10.3.7. Middle East and Africa (MEA)

10.4. Market Attractiveness Analysis By Region

11. North America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Product

11.3.3. By Indication

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Latin America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Argentina

12.3.1.4. Rest of Latin America

12.3.2. By Product

12.3.3. By Indication

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Europe Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. Russia

13.3.1.7. Rest of Europe

13.3.2. By Product

13.3.3. By Indication

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. East Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.1.4.

14.3.2. By Product

14.3.3. By Indication

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Product

15.3.3. By Indication

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. Oceania Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product

16.3.3. By Indication

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Middle East and Africa Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Turkey

17.3.1.3. Northern Africa

17.3.1.4. South Africa

17.3.1.5. Rest of Middle East and Africa

17.3.2. By Product

17.3.3. By Indication

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Key and Emerging Countries Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. U.S. Antibody Testing Market Analysis

18.2.1. By Product

18.2.2. By Indication

18.2.3. By End User

18.3. Canada Antibody Testing Market Analysis

18.3.1. By Product

18.3.2. By Indication

18.3.3. By End User

18.4. Mexico Antibody Testing Market Analysis

18.4.1. By Product

18.4.2. By Indication

18.4.3. By End User

18.5. Argentina Antibody Testing Market Analysis

18.5.1. By Product

18.5.2. By Indication

18.5.3. By End User

18.6. Brazil Antibody Testing Market Analysis

18.6.1. By Product

18.6.2. By Indication

18.6.3. By End User

18.7. U.K. Antibody Testing Market Analysis

18.7.1. By Product

18.7.2. By Indication

18.7.3. By End User

18.8. Germany Antibody Testing Market Analysis

18.8.1. By Product

18.8.2. By Indication

18.8.3. By End User

18.9. France Antibody Testing Market Analysis

18.9.1. By Product

18.9.2. By Indication

18.9.3. By End User

18.10. Italy Antibody Testing Market Analysis

18.10.1. By Product

18.10.2. By Indication

18.10.3. By End User

18.11. Spain Antibody Testing Market Analysis

18.11.1. By Product

18.11.2. By Indication

18.11.3. By End User

18.12. Russia Antibody Testing Market Analysis

18.12.1. By Product

18.12.2. By Indication

18.12.3. By End User

18.13. China Antibody Testing Market Analysis

18.13.1. By Product

18.13.2. By Indication

18.13.3. By End User

18.14. Japan Antibody Testing Market Analysis

18.14.1. By Product

18.14.2. By Indication

18.14.3. By End User

18.15. South Korea Antibody Testing Market Analysis

18.15.1. By Product

18.15.2. By Indication

18.15.3. By End User

18.16. India Antibody Testing Market Analysis

18.16.1. By Product

18.16.2. By Indication

18.16.3. By End User

18.17. Indonesia Antibody Testing Market Analysis

18.17.1. By Product

18.17.2. By Indication

18.17.3. By End User

18.18. Malaysia Antibody Testing Market Analysis

18.18.1. By Product

18.18.2. By Indication

18.18.3. By End User

18.19. Australia Antibody Testing Market Analysis

18.19.1. By Product

18.19.2. By Indication

18.19.3. By End User

18.20. New Zealand Antibody Testing Market Analysis

18.20.1. By Product

18.20.2. By Indication

18.20.3. By End User

18.21. GCC Countries Antibody Testing Market Analysis

18.21.1. By Product

18.21.2. By Indication

18.21.3. By End User

18.22. Turkey Antibody Testing Market Analysis

18.22.1. By Product

18.22.2. By Indication

18.22.3. By End User

18.23. South Africa Antibody Testing Market Analysis

18.23.1. By Product

18.23.2. By Indication

18.23.3. By End User

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Share Analysis of Top Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Deep Dive

20.2.1. Thermo Fisher Scientific.

20.2.1.1. Company Overview

20.2.1.2. Product Overview

20.2.1.3. Profitability by Market Segments (Service/Channel/Region)

20.2.1.4. Sales Footprint

20.2.1.5. Strategy Overview

20.2.1.5.1. Marketing Strategy

20.2.1.5.2. Service Strategy

20.2.1.5.3. Channel Strategy

20.2.2. Abbott Laboratories

20.2.2.1. Company Overview

20.2.2.2. Product Overview

20.2.2.3. Profitability by Market Segments (Service/Channel/Region)

20.2.2.4. Sales Footprint

20.2.2.5. Strategy Overview

20.2.2.5.1. Marketing Strategy

20.2.2.5.2. Service Strategy

20.2.2.5.3. Channel Strategy

20.2.3. Bio-Rad Laboratories, Inc.

20.2.3.1. Company Overview

20.2.3.2. Product Overview

20.2.3.3. Profitability by Market Segments (Service/Channel/Region)

20.2.3.4. Sales Footprint

20.2.3.5. Strategy Overview

20.2.3.5.1. Marketing Strategy

20.2.3.5.2. Service Strategy

20.2.3.5.3. Channel Strategy

20.2.4. Beckton, Dickinson and Company

20.2.4.1. Company Overview

20.2.4.2. Product Overview

20.2.4.3. Profitability by Market Segments (Service/Channel/Region)

20.2.4.4. Sales Footprint

20.2.4.5. Strategy Overview

20.2.4.5.1. Marketing Strategy

20.2.4.5.2. Service Strategy

20.2.4.5.3. Channel Strategy

20.2.5. F. Hoffmann-La Roche

20.2.5.1. Company Overview

20.2.5.2. Product Overview

20.2.5.3. Profitability by Market Segments (Service/Channel/Region)

20.2.5.4. Sales Footprint

20.2.5.5. Strategy Overview

20.2.5.5.1. Marketing Strategy

20.2.5.5.2. Service Strategy

20.2.5.5.3. Channel Strategy

20.2.6. Agilent Technologies

20.2.6.1. Company Overview

20.2.6.2. Product Overview

20.2.6.3. Profitability by Market Segments (Service/Channel/Region)

20.2.6.4. Sales Footprint

20.2.6.5. Strategy Overview

20.2.6.5.1. Marketing Strategy

20.2.6.5.2. Service Strategy

20.2.6.5.3. Channel Strategy

20.2.7. DiaSorin

20.2.7.1. Company Overview

20.2.7.2. Product Overview

20.2.7.3. Profitability by Market Segments (Service/Channel/Region)

20.2.7.4. Sales Footprint

20.2.7.5. Strategy Overview

20.2.7.5.1. Marketing Strategy

20.2.7.5.2. Service Strategy

20.2.7.5.3. Channel Strategy

20.2.8. Zeus Scientific

20.2.8.1. Company Overview

20.2.8.2. Product Overview

20.2.8.3. Profitability by Market Segments (Service/Channel/Region)

20.2.8.4. Sales Footprint

20.2.8.5. Strategy Overview

20.2.8.5.1. Marketing Strategy

20.2.8.5.2. Service Strategy

20.2.8.5.3. Channel Strategy

20.2.9. Abcam

20.2.9.1. Company Overview

20.2.9.2. Product Overview

20.2.9.3. Profitability by Market Segments (Service/Channel/Region)

20.2.9.4. Sales Footprint

20.2.9.5. Strategy Overview

20.2.9.5.1. Marketing Strategy

20.2.9.5.2. Service Strategy

20.2.9.5.3. Channel Strategy

20.2.10. Trinity Biotech

20.2.10.1. Company Overview

20.2.10.2. Product Overview

20.2.10.3. Profitability by Market Segments (Service/Channel/Region)

20.2.10.4. Sales Footprint

20.2.10.5. Strategy Overview

20.2.10.5.1. Marketing Strategy

20.2.10.5.2. Service Strategy

20.2.10.5.3. Channel Strategy

20.2.11. Werfen (Biokit)

20.2.11.1. Company Overview

20.2.11.2. Product Overview

20.2.11.3. Profitability by Market Segments (Service/Channel/Region)

20.2.11.4. Sales Footprint

20.2.11.5. Strategy Overview

20.2.11.5.1. Marketing Strategy

20.2.11.5.2. Service Strategy

20.2.11.5.3. Channel Strategy

20.2.12. Promega

20.2.12.1. Company Overview

20.2.12.2. Product Overview

20.2.12.3. Profitability by Market Segments (Service/Channel/Region)

20.2.12.4. Sales Footprint

20.2.12.5. Strategy Overview

20.2.12.5.1. Marketing Strategy

20.2.12.5.2. Service Strategy

20.2.12.5.3. Channel Strategy

20.2.13. BioLegend

20.2.13.1. Company Overview

20.2.13.2. Product Overview

20.2.13.3. Profitability by Market Segments (Service/Channel/Region)

20.2.13.4. Sales Footprint

20.2.13.5. Strategy Overview

20.2.13.5.1. Marketing Strategy

20.2.13.5.2. Service Strategy

20.2.13.5.3. Channel Strategy

20.2.14. Meridian Bioscience

20.2.14.1. Company Overview

20.2.14.2. Product Overview

20.2.14.3. Profitability by Market Segments (Service/Channel/Region)

20.2.14.4. Sales Footprint

20.2.14.5. Strategy Overview

20.2.14.5.1. Marketing Strategy

20.2.14.5.2. Service Strategy

20.2.14.5.3. Channel Strategy

20.2.15. Bio-Techne (R&D Systems)

20.2.15.1. Company Overview

20.2.15.2. Product Overview

20.2.15.3. Profitability by Market Segments (Service/Channel/Region)

20.2.15.4. Sales Footprint

20.2.15.5. Strategy Overview

20.2.15.5.1. Marketing Strategy

20.2.15.5.2. Service Strategy

20.2.15.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables:

Table 01: COVID-19 Region-wise Analysis

Table 02: Pipeline Assessment of Antibody Tests

Table 03: Global Antibody Testing Market Value (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, by Product Type

Table 04: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Indication

Table 05: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by End User

Table 06: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Region

Table 07: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 08: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 09: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 10: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 11: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 12: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 13: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 14: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 15: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 16: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 17: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 18: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 19: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 20: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 21: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 22: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 23: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 24: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 25: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 26: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 27: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 28: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 29: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 30: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

Table 31: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country

Table 32: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type

Table 33: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication

Table 34: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users


• 英文レポート名:Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand
• 日本語訳:抗体検査の世界市場
• レポートコード:PMR201210お問い合わせ(見積依頼・ご注文・質問)